Financials data is unavailable for this security.
View more
Year on year Merck KGaA 's revenues fell -5.57% from 22.23bn to 20.99bn. This along with an increase in the cost of goods sold expense has contributed to a reduction in net income from 3.33bn to 2.82bn, a -15.07% decrease.
Gross margin | 58.22% |
---|---|
Net profit margin | 12.61% |
Operating margin | 15.94% |
Return on assets | 5.34% |
---|---|
Return on equity | 9.51% |
Return on investment | 6.60% |
More ▼
Cash flow in EURView more
In 2023, Merck KGaA increased its cash reserves by 6.90%, or 128.00m. The company earned 3.78bn from its operations for a Cash Flow Margin of 18.03%. In addition the company used 1.89bn on investing activities and also paid 1.73bn in financing cash flows.
Cash flow per share | 2.19 |
---|---|
Price/Cash flow per share | 14.91 |
Book value per share | 14.08 |
---|---|
Tangible book value per share | 1.98 |
More ▼
Balance sheet in EURView more
Current ratio | 1.31 |
---|---|
Quick ratio | 0.8391 |
Total debt/total equity | 0.3763 |
---|---|
Total debt/total capital | 0.2729 |
More ▼
Growth rates in EUR
SmartText is unavailable
Div yield(5 year avg) | -- |
---|---|
Div growth rate (5 year) | -- |
Payout ratio (TTM) | 10.81% |
EPS growth(5 years) | 21.40 |
---|---|
EPS (TTM) vs TTM 1 year ago | -14.60 |
More ▼